April 14, 2021
Intellectual Property Magazine
The U.S. Court of Appeals for the Fourth Circuit ruled in favor of Finnegan client Combe in another trademark dispute over the VAGISIL trademark. The court ruled that Dr. August Wolff’s VAGISAN mark for feminine healthcare products would cause consumer confusion with Combe’s VAGISIL mark, which has proven its strength as a leader in the feminine-care product space for several decades. Wolff argued that the district court erred in finding that ‘Vagisil’ and ‘Vagisan’ are “sufficiently similar,” but the appeals court disagreed.
Doug Rettew, Anna Naydonov, and Sydney English represented Combe in the district court case and the appeal. They said, “This marks another milestone for the client’s enforcement efforts and comes on the heels of a separate recent trial victory before the Trademark Trial and Appeal Board, where VAGISERT was refused as confusingly similar to Combe’s Vagisil and Vagistat marks.”
Read “Personal-Care Company Combe Victorious in Trademark Appeal”
Award/Ranking
Best Lawyers in Germany Recognizes Dr. Dr. Jochen Herr in Recent Rankings
July 16, 2026
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.